Frątczak A, Polak K, Szczepanek M, Lis-Święty A. The role of proprotein convertase subtilisin/kexin type 9
(PCSK9) in the pathophysiology of psoriasis and systemic
lupus erythematosus. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2022;39(4):645-650. doi:10.5114/ada.2022.118919.
APA
Frątczak , A., Polak, K., Szczepanek, M., & Lis-Święty, A. (2022). The role of proprotein convertase subtilisin/kexin type 9
(PCSK9) in the pathophysiology of psoriasis and systemic
lupus erythematosus. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 39(4), 645-650. https://doi.org/10.5114/ada.2022.118919
Chicago
Frątczak , Aleksandra, Karina Polak, Michał Szczepanek, and Anna Lis-Święty. 2022. "The role of proprotein convertase subtilisin/kexin type 9
(PCSK9) in the pathophysiology of psoriasis and systemic
lupus erythematosus". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 39 (4): 645-650. doi:10.5114/ada.2022.118919.
Harvard
Frątczak , A., Polak, K., Szczepanek, M., and Lis-Święty, A. (2022). The role of proprotein convertase subtilisin/kexin type 9
(PCSK9) in the pathophysiology of psoriasis and systemic
lupus erythematosus. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 39(4), pp.645-650. https://doi.org/10.5114/ada.2022.118919
MLA
Frątczak , Aleksandra et al. "The role of proprotein convertase subtilisin/kexin type 9
(PCSK9) in the pathophysiology of psoriasis and systemic
lupus erythematosus." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 39, no. 4, 2022, pp. 645-650. doi:10.5114/ada.2022.118919.
Vancouver
Frątczak A, Polak K, Szczepanek M, Lis-Święty A. The role of proprotein convertase subtilisin/kexin type 9
(PCSK9) in the pathophysiology of psoriasis and systemic
lupus erythematosus. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2022;39(4):645-650. doi:10.5114/ada.2022.118919.
Inflammation and atherogenic dyslipidaemia are often observed in skin diseases and represent an increased risk of cardiovascular disorders. Proprotein convertase subtilisin/kexin type 9 plays an important role in the regulation of serum low-density lipoprotein cholesterol levels. Its biological role, however, seems to go much beyond the regulation of cholesterol metabolism. The article presents potential pathophysiological links between inflammatory process and lipid disorders based on the example of psoriasis and systemic lupus erythematosus.
